VC firms
R42 actively invents and finances deep science ventures. We will work with you from the pre-seed inve
Overview
Phone
+1 650-281-9220
Investment Type
Venture Capital
Investment Stage
Pre-Seed; Seed
Portfolio 3
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 20, 2026 | Edinburgh AI Ecommerce Firm Raises Over £1M In New Investment | Edinburgh-based startup stampfree.ai has successfully raised £1,029,968 in new investment, strengthening the company’s mission to modernise ecommerce logistics through social media customer experiences and AI label-free parcel technology. T... |
| Feb 10, 2026 | xWatts closes £1.6M to expand AI-powered energy management solutions | London-based xWatts, an intelligent energy management platform focused on decarbonising complex real estate assets, has closed a £1.6 million seed funding round. The investment was led by Cambridge Enterprise Ventures, with participation fr... |
| May 14, 2025 | Soopra AI raises $1M to make AI-driven expert personas into agents Your vote of support is important to us and it helps us keep the content FREE. One click below supports our mission to provide free, deep, and relevant content. Join our community on YouTube Join the community that includes more ... | Soopra AI, a company that provides on-demand artificial intelligence personas from experts for education and insights, announced today it raised $1 million in pre-seed funding to launch a platform for AI agents that can perform advanced fun... |
| Aug 8, 2024 | Healx Secures $47 Million to Tackle Rare Diseases with AI Innovations | In a significant leap for the biotech sector, Healx, a clinical-stage company based in Cambridge, UK, has successfully raised $47 million in a Series C funding round. This infusion of capital is not just a financial boost; it’s a lifeline f... |
| Aug 7, 2024 | Healx: Clinical-Stage Biotech Company Secures $47 Million In Series C | Healx, an AI-enabled, clinical-stage biotech company specializing in rare diseases, announced it has raised $47 million in a Series C round. This Series C round was co-led by Silicon Valley-based R42 Group and Atomico, one of Europe’s large... |
| Oct 13, 2022 | KetoSwiss secures $4 million pre-seed capital | |
| Oct 13, 2022 | KetoSwiss secures $4 million | |
| Jun 14, 2022 | Spirea, a startup developing antibody drug conjugates in cancer, nabs $3 million | Cambridge-based biotech company Spirea has raised $3 million to advance a new generation of antibody drug conjugate (ADC) therapeutics. The round was co-led by Jonathan Milner and Cambridge Enterprise, with backing from R42 Group, ACF Inves... |
| Jul 1, 2021 | Moving us one step closer to Tony Starks’ Holotable, VividQ raises £11 million | Next generation display and device makers in the US, China, and Japan are already employing Cambridge-based VividQ’s computer-generated holography technologies, now it’s simply a matter of waiting before Tony Starks’ holotable moves from sc... |
Show more
Reviews 0
FAQ about R42 Group
How many startups has R42 Group invested in?
R42 Group has 3 portfolio companies on Parsers VC, among them xWatts and Concr.
What has the press written about R42 Group?
Parsers VC has collected 17 articles mentioning R42 Group, among them “Edinburgh AI Ecommerce Firm Raises Over £1M In New Investment” (May 20, 2026) and “xWatts closes £1.6M to expand AI-powered energy management solutions” (Feb 10, 2026).
Is R42 Group still active?
Yes, R42 Group is active; its latest activity on Parsers VC dates from Jun 2, 2026.